For Media Inquiries:
The Purchaser Business Group on Health calls on Congress to continue efforts to rein in drug prices, despite Sunday’s announcement by Sen. Joe Manchin III (D-W.Va.) that he could not support President Biden’s Build Back Better Act, which included provisions to protect the American people from high prescription drug costs.
The Purchaser Business Group on Health (PBGH) commends Sen. Mike Braun (R-IN) and Sen. Tammy Baldwin (D-WI) for introducing the Healthy Competition for Better Care Act.
The Employers’s Prescription for Affordable Drugs (EmployersRx) coalition applauds the work of congressional leaders to reach agreement regarding prescription drug provisions to be included in the Build Back Better Act.
The Purchaser Business Group on Health (PBGH) commends congressional negotiators who struck a landmark deal to reform the prescription drug market.
The Purchaser Business Group on Health is profoundly disappointed that the budget reconciliation framework announced today by President Biden omits any policies to deal with unaffordable prescription drugs.
On Sept. 30, the Departments of Health and Human Services, Labor and Treasury, released an interim final rule (IFR) implementing the No Surprises Act.
Covered California, the California Public Employees’ Retirement System (CalPERS) and the Purchaser Business Group on Health (PBGH) are partnering to launch a pilot program to promote improvement in primary care which will benefit all Californians.
Patients and employers urge the House Ways and Means and Energy and Commerce Committees to move forward with H.R. 3, a bill that will empower Medicare to negotiate lower drug prices on behalf of Americans.
Congressional leaders are currently drafting legislation that would allow the federal government to negotiate the price of high-cost drugs and those newly entering the market.
The settlement agreement achieved in the Sutter Health case, along with the injunctive relief, will have a significant and beneficial economic impact.